Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma

Oncogene

Volumn 22, Issue 46, 2003, Pages 7233-7242

  Ferber, Matthew J ^a   Thorland, Erik C ^a   Brink, Antoinette A T P ^b   Rapp, Anton K ^b   Phillips, Leslie A ^c   McGovern, Renee ^c   Gostout, Bobbie S ^c   Cheung, Tak Hong ^d   Chung, Tong Kwok Hung ^d   Fu, Wong Yick ^d   Smith, David I ^c  

^a MAYO GRADUATE SCHOOL   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAYO CLINIC   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

c myc; Cervical cancer; Common fragile sites; Human papillomavirus; Viral integration

Indexed keywords

VIRUS DNA;

ARTICLE; CHROMOSOME 8Q; CLINICAL ARTICLE; COMMON FRAGILE SITE; GENE LOCUS; HUMAN; HUMAN GENOME; HUMAN TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; UTERINE CERVIX CARCINOMA; VIRUS DNA CELL DNA INTERACTION; VIRUS TYPING; WART VIRUS;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; CROSSING OVER, GENETIC; FEMALE; GENES, MYC; HUMANS; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0242720711     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207006     Document Type: Article

References (57)

1. Ahmad SI, Hanaoka F and Kirk SH. (2002). BioEssays, 24, 439-448.
2. Bechtold V, Beard P and Raj K. (2003). J. Virol., 77, 2021-2028.
3. Boldog FL, Gemmill RM, Wilke CM, Glover TW, Nilsson AS, Chandrasekharappa SC, Brown RS, Li FP and Drabkin HA. (1993). Proc. Natl. Acad. Sci. USA, 90, 8509-8513.
4. Bosch FX, Lorincz A, Munoz N, Meijer CJ and Shah KV. (2002). J. Clin. Pathol, 55, 244-265.
5. Boxer LM and Dang CV. (2001). Oncogene, 20, 5595-5610.
6. Boyer SN, Wazer DE and Band V. (1996). Cancer Res., 56, 4620-4624.
7. Brink AA, Wiegant JC, Szuhai K, Tanke HJ, Kenter GG, Fleuren GJ, Schuuring E and Raap AK. (2002). Cancer Genet. Cytogenet., 134, 145-150.
8. Casper AM, Nghiem P, Arlt MF and Glover TW. (2002). Cell, 111, 779-789.
9. Cha RS and Kleckner N. (2002). Science, 297, 602-606.
10. Cho KR. (1998). The Genetic Basis of Human Cancer. Vogelstein B and Kinzler K (eds). McGraw-Hill: New York, pp. 631-637.
11. Couturier J, Sastre-Garau X, Schneider-Maunoury S, Labib A and Orth G. (1991). J. Virol., 65, 4534-4538.
12. Crook T, Storey A, Almond N, Osborn K and Crawford L. (1988). Proc. Natl. Acad. Sci. USA, 85, 8820-8824.
13. Cullen AP, Reid R, Campion M and Lorincz AT. (1991). J. Virol., 65, 606-612.
14. Durst M, Croce CM, Gissmann L, Schwarz E and Huebner K. (1987). Proc. Natl. Acad. Sci. USA, 84, 1070-1074.
15. Eidelman FJ, Fuks A, DeMarte L, Taheri M and Stanners CP. (1993). J. Cell Biol., 123, 467-475.
16. Ferber MJ, Montoya DP, Yu C, Aderca I, McGee A, Thorland EC, Nagorney DM, Gostout BS, Burgart LJ, Boix L, Bruix J, McMahon BJ, Cheung TH, Chung TK, Wong YF, Smith DI and Roberts LR. (2003). Oncogene, 24, 3813-3820.
17. Fretland AJ and Omiecinski CJ. (2000). Chem. Biol. Interact., 129, 41-59.
18. Gallego MI, Schoenmakers EF, Van de Ven WJ and Lazo PA. (1997). Mol. Carcinogen., 19, 114-121.
19. Glover TW, Berger C, Coyle J and Echo B. (1984). Hum. Genet., 67, 136-142.
20. Glover TW and Stein CK. (1987). Am. J. Hum. Genet., 41, 882-890.
21. Glover TW and Stein CK. (1988). Am. J. Hum. Genet., 43, 265-273.
22. Gonzalez GA and Montminy MR. (1989). Cell, 59, 675-680.
23. Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Munoz N, Bosch FX, Shah K and Cho KR. (1997). Cancer Res., 57, 4692-4698.
24. Ham J, Dostatni N, Gauthier JM and Yaniv M. (1991). Trends Biochem. Sci., 16, 440-444.
25. Howley PM. (1996). Fields Virology, 3rd edn. Fields B, Howley PM, Griffin DE, Lamb RA, Martin MA, Roitman B, Straus SE and Knipe DM (eds). Lippincott-Raven: Philadelphia, pp. 2045-2076.
26. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR and Schiller JT. (1989). EMBO J., 8, 3905-3910.
27. Huebner K, Garrison PN, Barnes LD and Croce CM. (1998). Annu. Rev. Genet., 32, 7-31.
28. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW. (1994). Science, 266, 2011-2015.
29. Koopman LA, Szuhai K, van Eendenburg JD, Bezrookove V, Kenter GG, Schuuring E, Tanke H and Fleuren GJ. (1999). Cancer Res., 59, 5615-5624.
30. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson AB, Temple GF and Lorincz AT. (1988). Am. J. Obstet. Gynecol., 159, 293-296.
31. Lazo PA, DiPaolo JA and Popescu NC. (1989). Cancer Res., 49, 4305-4310.
32. Le Beau MM, Drabkin H, Glover TW, Gemmill R, Rassool FV, McKeithan TW and Smith DI. (1998). Genes Chromosomes Cancer, 21, 281-289.
33. Liu CX, Musco S, Lisitsina NM, Yaklichkin SY and Lisitsyn NA. (2000). Genomics, 69, 271-274.
34. Macville M, Schrock E, Padilla-Nash H, Keck C, Ghadimi BM, Zimonjic D, Popescu N and Ried T. (1999). Cancer Res., 59, 141-150.
35. Mayr B and Montminy M. (2001). Nat. Rev. Mol. Cell. Biol., 2, 599-609.
36. McBride AA, Romanczuk H and Howley PM. (1991). J. Biol. Chem., 266, 18411-18414.
37. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddie SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA. (1997). Cell, 90, 785-795.
38. Munger K. (2002). Front. Biosci., 7, d641-d649.
39. Pelengaris S, Khan M and Evan G. (2002). Nat. Rev. Cancer, 2, 764-776.
40. Pillutla RC, Shimamoto A, Furuichi Y and Shatkin AJ. (1998). Genomics, 54, 351-353.
41. Popescu NC and DiPaolo JA. (1989). Cancer Genet. Cytogenet., 42, 157-171.
42. Popescu NC, Zimonjic D and DiPaolo JA. (1990). Hum. Genet., 84, 383-386.
43. Rassool FV, McKeithan TW, Neilly ME, van Melle E, Espinosa Rd and Le Beau MM. (1991). Proc. Natl. Acad. Sci. USA, 88, 6657-6661.
44. Ratsch A, Joos S, Kioschis P and Lichter P. (2002). Exp. Cell Res., 273, 12-20.
45. Sarkar G, Turner RT and Bolander ME. (1993). PCR Methods Appl., 2, 318-322.
46. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. (1990). Cell, 63, 1129-1136.
47. Schwartz SM, Daling JR, Shera KA, Madeleine MM, McKnight B, Galloway DA, Porter PL and McDougall JK. (2001). J. Clin. Oncol., 19, 1906-1915.
48. Shah KV and Howley PM. (1996). Fields Virology, 3rd edn. Fields BN, Howley PM, Griffin DE, Lamb RA, Martin MA, Roitman B, Straus SE and Knipe DM. (eds). Lippincott-Raven: Philadelphia, pp. 2077-2109.
49. Simmons DL, Satterthwaite AB, Tenen DG and Seed B. (1992). J. Immunol., 148, 267-271.
50. Thorland EC, Myers SL, Gostout BS and Smith DI. (2003). Oncogene, 22, 1225-1237.
51. Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS and Smith DI. (2000). Cancer Res., 60, 5916-5921.
52. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N. (1999). J. Pathol., 189, 12-19.
53. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U and Doeberitz MK. (2002). Oncogene, 21, 419-426.
54. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI and Glover TW. (1996). Hum. Mol. Genet., 5, 187-195.
55. Woodworth CD, Doniger J and DiPaolo JA. (1989). J. Virol., 63, 159-164.
56. Zimonjic DB, Druck T, Ohta M, Kastury K, Croce CM, Popescu NC and Huebner K. (1997). Cancer Res., 57, 1166-1170.
57. zur Hausen H. (1991). Virology, 184, 9-13.